App aims to slash stroke recurrence in 5,000 patients
NCT ID NCT07098143
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a smartphone app that gives personalized tips on managing stroke risk factors can reduce the chance of having another stroke. Over 5,000 people who recently had a mild-to-moderate stroke will use the app for one year. Researchers will track how many have another stroke and whether the app improves their understanding of stroke prevention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Individualized risk factor management application
What this could lead to
If successful, this app could become a simple, scalable tool to help stroke survivors lower their chance of having another stroke.
What could go wrong
This is an early-stage trial testing a behavioral intervention, not a drug. Results depend on how well people use the app, and the effect may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••